Organoid Culture and Drug Screening System

The organoid cluture and drug screening system aims to achieve efficient, precise, and standardized organoid production processes. It integrates primary cell seeding, precision observation, automated medium exchange, stable passage, and efficient harvesting, forming a complete and highly automated organoid culture protocol. This platform combines user-defined culture programs with advanced artificial intelligence technology, enabling intelligent analysis and prediction of cell status, real-time monitoring and optimization of the culture environment, and ensuring optimal growth conditions. The platform complies to GMP Grade A requirements and meets BSL-2/3 laboratory standards, establishing a safe and reliable cell culture environment.